These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort. Billings M, Dye BA, Iafolla T, Baer AN, Grisius M, Alevizos I. EBioMedicine; 2016 Oct; 12():270-279. PubMed ID: 27639822 [Abstract] [Full Text] [Related]
6. Salivary gland dysfunction and xerostomia in Sjögren's syndrome. Jensen SB, Vissink A. Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192 [Abstract] [Full Text] [Related]
7. Unstimulated whole salivary flow in Sjögren's Syndrome: systematic literature review and meta-analysis. Martínez-Ceballos MA, Aguilera N, Garzón-González KC, Cajamarca-Baron J, Alzate-Granados JP, Rojas-Villarraga A. Adv Rheumatol; 2021 Feb 03; 61(1):8. PubMed ID: 33536075 [Abstract] [Full Text] [Related]
8. The frequency of sicca symptoms and Sjögren's syndrome in patients with systemic sclerosis. Kobak S, Oksel F, Aksu K, Kabasakal Y. Int J Rheum Dis; 2013 Feb 03; 16(1):88-92. PubMed ID: 23441777 [Abstract] [Full Text] [Related]
10. Unstimulated whole saliva flow rate in relation to sicca symptoms in Hungary. Márton K, Madléna M, Bánóczy J, Varga G, Fejérdy P, Sreebny LM, Nagy G. Oral Dis; 2008 Jul 03; 14(5):472-7. PubMed ID: 18938274 [Abstract] [Full Text] [Related]
11. A comparison of salivary gland hypofunction in primary and secondary Sjögren's syndrome. Dawson LJ, Holt DJ, Higham SM, Longman LP, Field EA. Oral Dis; 2001 Jan 03; 7(1):28-30. PubMed ID: 11354918 [Abstract] [Full Text] [Related]
12. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome? Manthorpe R, Benoni C, Jacobsson L, Kirtava Z, Larsson A, Liedholm R, Nyhagen C, Tabery H, Theander E. Ann Rheum Dis; 2000 Jan 03; 59(1):54-60. PubMed ID: 10627428 [Abstract] [Full Text] [Related]
15. Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjögren's syndrome. Correlation with clinical, immunological and histological features. Rosas J, Ramos-Casals M, Ena J, García-Carrasco M, Verdu J, Cervera R, Font J, Caballero O, Ingelmo M, Pascual E. Rheumatology (Oxford); 2002 Jun 03; 41(6):670-5. PubMed ID: 12048294 [Abstract] [Full Text] [Related]
16. Minor salivary glands function is decreased in hyposalivation-related diseases. Wang Z, Li W, Hong X, Su JZ, Hua H, Peng X, Lv L, Yu GY. Arch Oral Biol; 2016 Sep 03; 69():63-70. PubMed ID: 27243418 [Abstract] [Full Text] [Related]
17. Oral candidiasis and Sjögren's syndrome. Soto-Rojas AE, Villa AR, Sifuentes-Osornio J, Alarcón-Segovia D, Kraus A. J Rheumatol; 1998 May 03; 25(5):911-5. PubMed ID: 9598890 [Abstract] [Full Text] [Related]
19. Autoimmune thyroiditis and primary Sjögren's syndrome: clinical and laboratory evidence of the coexistence of the two diseases. Hansen BU, Ericsson UB, Henricsson V, Larsson A, Manthorpe R, Warfvinge G. Clin Exp Rheumatol; 1991 May 03; 9(2):137-41. PubMed ID: 2060160 [Abstract] [Full Text] [Related]
20. Salivary chemokine levels in patients with primary Sjogren's syndrome. Lee YJ, Scofield RH, Hyon JY, Yun PY, Lee HJ, Lee EY, Lee EB, Song YW. Rheumatology (Oxford); 2010 Sep 03; 49(9):1747-52. PubMed ID: 20525739 [Abstract] [Full Text] [Related] Page: [Next] [New Search]